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LETTER TO THE EDITOR
Response to letters by Baethge et al. 
and Martino et al.
Steven Marwaha1,2*  and Andrew Thompson1,3
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Dear Editor,
We thank Baethge et al. (2017) and Martino et al. (2017) 
for their interest and comments on our comprehen-
sive literature review (Joyce et  al. 2016). We focussed 
on answering the question of whether treatment given 
earlier in illness course is more effective than later. As 
we suggest in our review, this is a central tenet of the 
scientific basis of espousing early intervention in men-
tal disorders including in bipolar disorders (Marwaha 
et al. 2016). The challenge is to identify methodologically 
robust evidence. Whilst we are cautious about the qual-
ity of current evidence, our review suggests that available 
treatments are more effective earlier in illness course. 
Our conclusions are based on ten studies included in the 
review. Eight studies, made up of two systematic reviews, 
and six incorporating primary evidence supported this 
conclusion. In 2 out of 10 of the included studies, this 
effect was rendered non-significant after adjusting for 
confounding.
Baethge et  al. state that our results do not align with 
their own work (Baethge et al. 2003a, b;Bratti et al. 2003). 
They suggest that this discrepancy may be due to omis-
sions in search terms that we used and secondly that our 
strategy of only including studies in which there was a 
direct comparison between people earlier and later in ill-
ness course is flawed because the latter group will include 
people who have poor prognosis or treatment resistance 
and the former with multiple prognoses. Martino et  al. 
also focus on this latter point. Both letters suggest that 
the staging model of bipolar disorder is a hypothesis and 
not proven.
We agree with Baethge et  al. and Martino et  al. that 
the evidence base to investigate our question is limited 
in several ways, and we were of course at pains to point 
this out in the extensive limitations section of the paper. 
Indeed in assessing quality, we highlighted the risk of 
multiple biases that exist in most of the studies examined 
(see figure 2 in paper).
In terms of Baethge et al.’s first point, the main reason 
for this discrepancy may be that our review and their 
work, in essence, answer distinct though not necessarily 
wholly mutually exclusive questions. Our review was not 
concerned with latency or delay before first treatment 
but with effectiveness of treatment after the first (or first 
few) episode(s), and assessing the literature in relation to 
episode number and treatment (not necessarily prophy-
laxis) and effectiveness. In our strategy, we specifically 
avoided the issue of conflating latency or delay with epi-
sode number, in part because delay to first treatment can 
be lengthy but is highly variable (Dagani et al. 2016), and 
may encompass a range of previous affective symptoms 
and episodes (Berk et  al. 2007; Howes et  al. 2011). In 
addition, latency/delay may be just as much a function of 
the response of services as illness course. We also noted 
that in many studies first admission was aligned to first 
episode something which is unlikely to be the case and 
confounds analyses in this area. Whilst of course there 
may be an association between latency/delay and episode 
number, the nature of this is unlikely to be linear. Indeed 
in their own work, Baethge et al. (2003a) found that these 
two parameters are distinct, in that they report “A greater 
therapeutic effect was demonstrated with increased 
severity of the illness prior to prophylaxis”, (where ill-
ness severity was defined as hospitalisation rate before 
prophylaxis), whilst latency did not show a relationship. 
We agree that had we included the terms “delay” we 
could have extracted more overlapping papers included 
in their review (Baethge et al. 2003b) but it is likely that 
our protocol (developed before the work began) would 
have excluded these papers as they would not have met 
our inclusion criteria.
We agree that the work within Bratti et al. (2003) does 
concern our central question more so, though again the 
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focus of that review appears to be pre-treatment episode 
number and its link to response to lithium treatment 
specifically. That paper concludes that there was not a 
clear and consistent signal. Our review covered both 
pharmacological (not only Lithium) and psychological 
treatments and found overall evidence in favour of the 
hypothesis that early treatment was more effective. Some 
discrepancy may be explained by the specificity of previ-
ous work focussing solely on Lithium and also its use as 
an acute treatment or in prophylaxis. Another reason for 
discrepancy may be that the evidence base that we inter-
preted contained five papers which were published after 
their review of 2003.
A major point raised by Baethge et al. as well as Mar-
tino et al., which we would partly agree with, is that those 
with multiple episodes have a worse prognosis than 
those with a first episode who would be made up of a 
group with varying prognoses (though unknown at the 
time of sampling). However, given the highly recurrent 
nature of bipolar disorder (Angst et al. 2003), it is likely 
that the vast majority of the first episode groups would 
be likely to go on to develop further episodes; for exam-
ple, 50% relapse in as little as a year (Tohen et al. 2003). 
This reduces the validity of claims that the conclusions of 
our review are entirely dependent on comparing good vs 
poor prognosis groups. Some people in the multiple epi-
sode groups are likely to have been treatment resistant 
although how many would fulfil strict criteria of having 
failed two treatment attempts (Gitlin 2006) in the current 
episode is unclear. We also agree that the heterogeneity 
in the literature makes comparisons difficult and indeed 
it is for this reason we did not attempt a meta-analysis. 
We agree with the suggestion of Martino et  al. that a 
longitudinal study examining effectiveness of treatment 
between many consecutive episodes experienced by the 
same patient would enable further understanding of this 
issue, though wonder how practicable this study design 
is.
Both Baethge et al. and Martino et al. raise the question 
of whether neuroprogression occurs within bipolar disor-
der and whether clinical staging is useful. We suggest in 
our paper that our results could be explained by this type 
of model, but agree that the evidence is not clear. In prin-
ciple, we would take the view suggested by Scott et  al. 
(2013) that clinical staging of bipolar disorder is a model 
with testable assumptions that require further study.
Finally, our esteemed colleagues all suggest that despite 
their doubts about the evidence, clinicians should con-
tinue to aim for early diagnosis and early treatment on 
ethical and clinical grounds. Whilst of course we agree, 
we cannot get away from the fact that especially in pub-
lically funded mental healthcare systems, clinical need 
and ethics are not the only actors on the stage. Policy 
decisions related to mental health service development 
require evidence that an approach is more clinically and 
cost-effective than the current framework. It is only by 
demonstrating this, whilst explaining the flaws in the 
literature, that a rationale for early intervention in bipo-
lar disorder may be advanced. We hope that our review 
forms part of this developing evidence base, though 
clearly more work is needed.
In conclusion, whilst we agree with many of the com-
ments on the methodological quality of the literature, 
our review conclusions are based on the available con-
temporaneous evidence. We suspect our differing results, 
and perhaps differing perspectives are likely to be due to 
incorporating this newer evidence and interpreting find-
ings alongside current hypotheses within the clinical 
staging model of mental disorders.
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